COM:INSTILBIO
Instil Bio
- Stock
Last Close
24.76
22/11 21:00
Market Cap
134.50M
Beta: -
Volume Today
91.17K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | 590.50K - | 590.50K 0% | ||||
average payables | 2.24M - | 4.53M 102.57% | 3.96M 12.53% | 1.79M 54.95% | ||
average receivables | 1.59M - | 1.59M 0% | ||||
book value per share | -0.11 - | -0.32 187.66% | 5.24 1,736.44% | 2.81 46.40% | 34.72 1,136.77% | |
capex per share | -0.01 - | -0.41 3,247.54% | -0.55 32.83% | -0.65 19.71% | -3.18 386.43% | |
capex to depreciation | -38 - | -198.50 422.37% | -21.01 89.41% | -14.13 32.77% | -4.34 69.25% | |
capex to operating cash flow | 0.14 - | 1.72 1,094.98% | 0.47 72.40% | 0.47 0.84% | 0.25 46.35% | |
capex to revenue | -368.23 - | |||||
cash per share | 0.14 - | 1.95 1,260.49% | 4.28 119.27% | 2.01 52.98% | 23.35 1,058.95% | |
days of inventory on hand | ||||||
days payables outstanding | 93.02 - | |||||
days sales outstanding | 8.39K - | |||||
debt to assets | 0.17 - | 0.26 54.13% | ||||
debt to equity | 0.22 - | 0.37 67.61% | ||||
dividend yield | ||||||
earnings yield | -0.00 - | -0.01 192.74% | -0.09 649.37% | -2.74 3,063.70% | -3.15 15.14% | |
enterprise value | 1.63B - | 3.03B 85.99% | 1.78B 41.37% | 117.78M 93.37% | 124.92M 6.06% | |
enterprise value over ebitda | -248.09 - | -89.01 64.12% | -11.42 87.17% | -0.59 94.85% | -1.46 147.52% | |
ev to operating cash flow | -307.71 - | -102.28 66.76% | -14.54 85.78% | -0.65 95.50% | -1.52 132.95% | |
ev to sales | 21.95K - | |||||
free cash flow per share | -0.10 - | -0.65 565.27% | -1.70 161.16% | -2.04 20.40% | -15.79 672.38% | |
free cash flow yield | -0.00 - | -0.02 565.27% | -0.10 303.57% | -3.24 3,169.78% | -2.07 36.14% | |
graham net net | -0.12 - | -0.92 663.25% | 3.77 509.10% | 1.10 70.82% | 8.00 627.96% | |
graham number | 0.51 - | 1.48 190.19% | 13.20 790.82% | 10.43 20.98% | 136.93 1,212.41% | |
income quality | 0.81 - | 0.78 3.30% | 0.78 0.74% | 0.81 3.63% | 0.53 34.90% | |
intangibles to total assets | 0 - | 0.05 Infinity% | 0.03 47.70% | 0 100% | 0 | |
interest coverage | -120.26 - | -17.38 85.55% | ||||
interest debt per share | 0.63 - | 13.59 2,052.02% | ||||
inventory turnover | ||||||
invested capital | 0.22 - | 0.37 67.61% | ||||
market cap | 1.64B - | 3.27B 99.74% | 1.81B 44.56% | 81.59M 95.50% | 49.56M 39.26% | |
net current asset value | -7.08M - | -112.47M 1,488.15% | 409.24M 463.85% | 150.85M 63.14% | 60.96M 59.59% | |
net debt to ebitda | 1.35 - | 7.10 424.22% | 0.24 96.60% | -0.18 174.80% | -0.88 386.01% | |
net income per share | -0.10 - | -0.31 192.74% | -1.48 384.94% | -1.72 16.49% | -24.00 1,292.69% | |
operating cash flow per share | -0.09 - | -0.24 180.13% | -1.15 381.35% | -1.39 20.72% | -12.61 806.64% | |
payables turnover | 3.92 - | |||||
receivables turnover | 0.04 - | |||||
research and ddevelopement to revenue | 140.57 - | |||||
return on tangible assets | -0.68 - | -0.12 81.72% | -0.26 112.01% | -0.46 75.41% | -0.48 3.55% | |
revenue per share | 0.00 - | |||||
roe | 0.94 - | 0.95 1.77% | -0.28 129.63% | -0.61 117.34% | -0.69 12.61% | |
roic | 0.95 - | 0.85 9.78% | -0.28 132.85% | -0.50 77.49% | -0.29 41.64% | |
sales general and administrative to revenue | 104.22 - | |||||
shareholders equity per share | -0.11 - | -0.32 187.66% | 5.24 1,736.44% | 2.81 46.40% | 34.72 1,136.77% | |
stock based compensation to revenue | 12.36 - | |||||
tangible asset value | -6.89M - | -55.42M 704.19% | 539.37M 1,073.16% | 363.61M 32.59% | 225.83M 37.89% | |
tangible book value per share | -0.11 - | -0.45 302.62% | 5.09 1,235.84% | 2.81 44.83% | 34.72 1,136.77% | |
working capital | 7.87M - | 232.86M 2,860.30% | 422.66M 81.51% | 236.59M 44.02% | 150.20M 36.51% |
All numbers in USD (except ratios and percentages)